2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Monday, September 23, 2019

1:45pm-3:15pm: Detection of genetic modifiers in PRKN

K. Ogaki, H. Nakaoka, K. Daida, A. Hayashida, A. Ikeda, Y. Li, H. Yoshino, M. Funayama, K. Nishioka, I. Inoue, N. Hattori (Tokyo, Japan)

Genetics · Les Muses Terrace, Level 3

1:45pm-3:15pm: Determining Outcome of Deep Brain Stimulation Surgery in Parkinson’s Disease Patients

E. Yoon, S. Ahmed, S. Bandres-Ciga, S. Scholz, C. Lungu, D. Hernandez, A. Singleton, D. Ehrlich (Bethesda, MD, USA)

Genetics · Les Muses Terrace, Level 3

1:45pm-3:15pm: Development of a web-based tool for systematic collection of phenotypes of hereditary movement disorders from medical literature

J. Lee, S. Fujioka, S. Hong, N. Kim, Y. Kim, H. Ma, Y. Tsuboi, Y. Kim (Anyang, Republic of Korea)

Genetics · Les Muses Terrace, Level 3

1:45pm-3:15pm: Development Of Anti-Parkinsonism Poly Herbal Sustained Release Formulation Composed Of Potential Traditional Plant Extracts

S. Jain, A. Jain, S. Bhargav (Sagar, India)

Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3

1:45pm-3:15pm: Development of Mucoadhesive Sustained Release Floating Tablets of Silymarin using Natural Polymer for Improved Anti-Parkinson Efficacy

D. Gugulothu, R. Nagapuri, DK. Khatri (Pune, India)

Neuropharmacology · Les Muses Terrace, Level 3

1:45pm-3:15pm: Diagnosis and management strategies used in series of Parkinson’s disease patients who experienced subthalamic nucleus deep brain stimulation induced mood elevation

L. Spiegel, J. Weinstein, J. Ostrem, A. Seritan (San Francisco, CA, USA)

Psychiatric Manifestations · Les Muses Terrace, Level 3

1:45pm-3:15pm: Diagnostic journeys of people with Parkinson’s disease in Kenya, sub-Saharan Africa

N. Fothergill Misbah, K. Hampshire, S. Moffatt, J. Kwasa, J. Hooker, R. Walker (Newcastle Upon Tyne, United Kingdom)

Other · Agora 2 West, Level 2

1:45pm-3:15pm: Difference in perception of the wearing-off between patients and physicians in Parkinson’s disease

Y. Tsuboi, R. Nakagawa, M. Ishido, Y. Yoshinaga, T. Hashimoto, T. Mishima, S. Fujioka (Fukuoka, Japan)

Quality of Life · Les Muses Terrace, Level 3

1:45pm-3:15pm: Differences in correlation with cardiac sympathetic denervation between depression and anhedonia in drug naïve Parkinson disease patients

H. Murakami, T. Shiraishi, T. Umehara, S. Omoto, H. Motegi, R. Nakada, T. Sato, A. Onda, H. Matsuno, T. Komatsu, K. Bono, K. Sakai, H. Mitsumura, Y. Iguchi (Tokyo, Japan)

Psychiatric Manifestations · Les Muses Terrace, Level 3

1:45pm-3:15pm: Different clinical entities of Segawa syndrome within a family

J. Sarangerel (Ulaanbaatar, Mongolia)

Rare Genetic and Metabolic Diseases · Les Muses Terrace, Level 3